# Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine

> **NCT01353534** · PHASE1,PHASE2 · COMPLETED · sponsor: **Intercell USA, Inc.** · enrollment: 276 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** A/H5N1 Antigen
- **DRUG:** Vaccine Enhancement Patch

## Key facts

- **NCT ID:** NCT01353534
- **Lead sponsor:** Intercell USA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-12
- **Final completion:** 2012-10
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2012-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01353534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01353534, "Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01353534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*